APA (7th ed.) Citation

Masiá, M., Robledano, C., López, N., Escolano, C., & Gutiérrez, F. x. (2011). Treatment for hepatitis C virus with pegylated interferon-α plus ribavirin induces anti-atherogenic effects on cardiovascular risk biomarkers in HIV-infected and -uninfected patients. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 66(8), 1861-1868.

Chicago Style (17th ed.) Citation

Masiá, M., C. Robledano, N. López, C. Escolano, and F. x. Gutiérrez. "Treatment for Hepatitis C Virus with Pegylated Interferon-α Plus Ribavirin Induces Anti-atherogenic Effects on Cardiovascular Risk Biomarkers in HIV-infected and -uninfected Patients." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 66, no. 8 (2011): 1861-1868.

MLA (8th ed.) Citation

Masiá, M., et al. "Treatment for Hepatitis C Virus with Pegylated Interferon-α Plus Ribavirin Induces Anti-atherogenic Effects on Cardiovascular Risk Biomarkers in HIV-infected and -uninfected Patients." JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 66, no. 8, 2011, pp. 1861-1868.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.